Runda Medical(SH:603108) Xin Lang Cai Jing·2025-11-25 02:04Core Viewpoint - RunDa Medical's stock has shown mixed performance in recent trading sessions, with a slight increase in price but a significant decline in revenue and profit year-over-year [1][2]. Financial Performance - As of September 30, 2025, RunDa Medical reported a revenue of 5.268 billion yuan, representing a year-over-year decrease of 14.70% [2]. - The company experienced a net profit loss of 163 million yuan, a substantial decline of 422.64% compared to the previous year [2]. Stock Performance - On November 25, 2025, RunDa Medical's stock price increased by 2.11%, reaching 16.45 yuan per share, with a total market capitalization of 9.93 billion yuan [1]. - Year-to-date, the stock has risen by 3.46%, with a 3.01% increase over the last five trading days and a 6.61% increase over the last 20 days, while it has decreased by 12.96% over the last 60 days [1]. Shareholder Information - As of September 30, 2025, the number of shareholders decreased to 64,800, a reduction of 1.05% from the previous period [2]. - The average number of circulating shares per shareholder increased by 1.06% to 9,317 shares [2]. Dividend Information - RunDa Medical has distributed a total of 373 million yuan in dividends since its A-share listing, with 165 million yuan distributed over the past three years [3]. Institutional Holdings - Among the top ten circulating shareholders, the Southern CSI 1000 ETF holds 4.4119 million shares, a decrease of 48,700 shares from the previous period [3]. - Hong Kong Central Clearing Limited is a new entrant among the top ten shareholders, holding 4.1516 million shares [3].